RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Critics

When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics.

News
Volkswagen to Exit China’s Xinjiang Region After 12 Years

The automaker has long been criticized by human rights activists for doing business in the territory, where China has repressed Muslim ethnic groups.

News
Overlooked No More: Margaret Getchell, Visionary Force at Macy’s

As the store’s first female executive, she helped turn it into what it is today, paving the way for other women to hold senior positions in retail.

News
The New Amazon Haul Storefront Is Feeding Our Endless Need to Shop

It is the shopping phenomenon of our times, and now it’s an Amazon store.

News
Why Do We Love the Macy’s Thanksgiving Day Parade So Much?

The nostalgia-fueled production has been the most-watched entertainment program in the United States for the past three years, ahead of the Oscars and the World Series.

News
Two Presidents, Two Policies, One Superpower: America in Transition

Even as President Biden brokers a cease-fire in Lebanon, President-elect Donald J. Trump is running his own foreign policy without waiting to be sworn in.

News
Inflation Concerns Loom as Trumponomics Revs Up

Investors are bracing for the latest data as the president-elect’s economic agenda of cutting immigration and taxes, while raising tariffs takes shape.

News
PCE, a Key Inflation Measure, Sped Up in October

Inflation has been stubborn in recent months. Now, President-elect Donald J. Trump’s tariffs loom as a potential risk.

News
As Congress Feuds Over Farm Bill, Growers Are ‘Stuck in Limbo’

The agriculture and nutrition measure was last updated in 2018 and originally expired two years ago. Farmers fear the Trump administration’s priorities will eclipse theirs next year.

News
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.

News